ADIAL PHARMACEUTICALS, INC. (ADIL) Stock Profile — Insider Trades & Financials

Smart-Money SignalNeutral · 53/100— Insiders are net buyers over 90 days ($3K, 1 buy vs 0 sales)

Net Income-$52.0M

EPS$-17.97

Market Cap$8.6M

Price Performance

Historical data including institutional events

Company Profile

Cary Claiborne

CEO & Executive Director

Company profile for Adial Pharmaceuticals, Inc. (ADIL) stock, with a description, list of executives, contact details and other key facts.

Founded: 2010
Employees: 1
Headquarters: Glen Allen, VA, United States
Website: adial.com

Peer ComparisonRevenue ($B)

▾

Loading company sections...

Smart-Money SignalNeutral · 53/100— Insiders are net buyers over 90 days ($3K, 1 buy vs 0 sales)

Net Income-$52.0M

EPS$-17.97

Market Cap$8.6M

Price Performance

Historical data including institutional events

Company Profile

Cary Claiborne

CEO & Executive Director

Company profile for Adial Pharmaceuticals, Inc. (ADIL) stock, with a description, list of executives, contact details and other key facts.

Founded: 2010
Employees: 1
Headquarters: Glen Allen, VA, United States
Website: adial.com

Peer ComparisonRevenue ($B)

▾

Smart-Money Signal

90-DAY POSTURE

53/ 100

NEUTRAL

Insiders are net buyers over 90 days ($3K, 1 buy vs 0 sales). Smart-money posture is balanced.

Insider flow · 90d$3K

Congress flow · 90dno activity

10b5-1 share—

Cluster selling0 officers

Price vs 52w34% of high

Cross-Section Event Timeline

INSIDERS · CONGRESS · EARNINGS

INSIDER GRANT / AWARDCary J. Claiborne (Chief Executive Officer) GRANT / AWARD ADILApr 7, 2026

INSIDER GRANT / AWARDRobertson H. Gilliland (Director) GRANT / AWARD ADILApr 7, 2026

INSIDER GRANT / AWARDKevin Schuyler (Director) GRANT / AWARD ADILApr 7, 2026

INSIDER GRANT / AWARDMatt Davidson (Chief Development Officer) GRANT / AWARD ADILJun 11, 2026

INSIDER BUYWendy B. Young (Director) BUY ADILJun 12, 2026

INSIDER GRANT / AWARDMatt Davidson (Chief Development Officer) GRANT / AWARD ADILJun 12, 2026

INSIDER BUYCoastlands Capital LP (10% Owner) BUY ADILJun 29, 2026

INSIDER BUYCoastlands Capital LP (10% Owner) BUY ADILJul 9, 2026

INSIDER BUYCoastlands Capital LP (10% Owner) BUY ADILJul 10, 2026

INSIDER BUYCoastlands Capital LP (10% Owner) BUY ADILJul 14, 2026

INSIDER BUYCoastlands Capital LP (10% Owner) BUY ADILJul 16, 2026

INSIDER GRANT / AWARDWendy B. Young (Director) GRANT / AWARD ADILSep 17, 2026

⚡

Core Efficiency

ROE?

135.47%

ROA?

-178.73%

D/E Ratio?

-0.75

📊

Profitability Ratios

Current Ratio?

5.63

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Nov 17, 2026 (in 35 days)

Quarterly Report (10-Q) — Based on filing pattern

Nov 17, 2026

Predicted10-Q

Aug 14, 2026

10-QQ2 202645d after period end

May 8, 2026

10-QQ1 202638d after period end

Mar 5, 2026

10-KQ4 202564d after period end

Mar 5, 2026

10-KFY 202564d after period end

Nov 13, 2025

10-QQ3 202544d after period end

Aug 13, 2025

10-QQ2 202544d after period end

May 14, 2025

10-QQ1 202544d after period end

Mar 4, 2025

10-KQ4 202463d after period end

Data Freshness

Financial Data

1mo ago

Latest filing: 2026-08-14

SEC Metadata

1mo ago

Latest filing: 2026-08-14

Loading company sections...

ADIAL PHARMACEUTICALS, INC.

Price Performance

Company Profile

ADIAL PHARMACEUTICALS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

ADIAL PHARMACEUTICALS, INC.

Price Performance

Company Profile

The morning brief, before the bell.

ADIAL PHARMACEUTICALS, INC.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades